Montelukast, an asthma drug, can bind to and block a crucial SARS-CoV-2 protein. This discovery sets the stage for a new class of antiviral drugs, designed to target and interfere with the virus' immunosuppressive tactics.
Subscribe to:
Post Comments (Atom)
< + > Healthcare IT Failures – Healthcare IT Today Podcast Episode 195
For the 195th episode of the Healthcare IT Today Podcast , we are taking a look at healthcare IT failures! We kick this episode off by debat...
No comments:
Post a Comment